Our brands

Fulzos

Fulzos is a hormonal treatment for advanced or metastatic breast cancer in postmenopausal women. It contains fulvestrant, an estrogen receptor antagonist that degrades the estrogen receptor, preventing estrogen from stimulating cancer cell growth.

Fulzos
  • Fulzos Injection 250mg/5ml

    Fulvestrant IP 50 mg Ethanol (96%) IP 10%w/v Excipients q.s.

subscribe

Keep yourself updated with our new product information and much more.

Copyright © All Rights Reserved by Hetero Healthcare Limited